Replies to post #432763 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

It is However Missing’s responsibility to fund the operation as cheaply as possible with as little dilution as possible, which he can do through LPC only if the $AVXL SP isn’t falling like a rock.

And remember there isn't a quarter that goes by without funding the operation from selling shares to maintain the runway.

[BAR123]

Hoskuld, I agree with everything you say. I believe the next step for Anavex will be something like an investor day. Since we have so much data that could be released over the next several months I think sometime may be mid October we get this investor day where the company goes through, their entire pipeline and the status of all indications. I also think during this time we will find out as a major headline what the FDA expects out of us and accelerated approvals will be forthcoming. Obviously for Rett Syndrome, we will get the expected. Very good to great data and will be submitting an NDA for that before the end of the year. All updates should drive the stock price significantly higher and may be back to the old highs.